Neurocrine Biosciences (NBIX) Cash & Current Investments (2010 - 2026)
Neurocrine Biosciences (NBIX) reported Cash & Current Investments of $389.8 million for Q2 2026, down 60.0% from $975.6 million a year earlier and down 70.4% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences posted Cash & Current Investments of $1.48 billion, up 37.6% from FY2024.
- Cash & Current Investments has increased for four consecutive years, with a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $1.08 billion in FY2024 (+3.5%), $1.04 billion in FY2023 (+4.3%), $997.1 million in FY2022 (+39.6%) and $714.5 million in FY2021 (-11.2%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q1 2017.
- Year over year, Cash & Current Investments gained in four of the last eight quarters, with an average decline of 0.6%.
- The high point for year-over-year Cash & Current Investments in five years was Q2 2023 (growth of 50.7%); the low point was Q2 2026 (a decline of 60.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.32 billion (Q1 2026), $1.48 billion (Q4 2025) and $1.11 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn | 389.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 389.80 Mn |
| Mar 31, 2026 | 1.32 Bn |
| Dec 31, 2025 | 1.48 Bn |
| Sep 30, 2025 | 1.11 Bn |
| Jun 30, 2025 | 975.60 Mn |
| Mar 31, 2025 | 943.50 Mn |
| Dec 31, 2024 | 1.08 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.04 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.04 Bn |
| Sep 30, 2023 | 1.10 Bn |
| Jun 30, 2023 | 976.70 Mn |
| Mar 31, 2023 | 894.60 Mn |
| Dec 31, 2022 | 997.10 Mn |
| Sep 30, 2022 | 799.40 Mn |
| Jun 30, 2022 | 648.30 Mn |
| Mar 31, 2022 | 664.90 Mn |
| Dec 31, 2021 | 714.50 Mn |
| Sep 30, 2021 | 765.90 Mn |
API Access
Neurocrine Biosciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();